MCQOPTIONS
Saved Bookmarks
| 1. |
India's first indigenous mRNA vaccine candidate has received approval from the DGCI to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by which of the following? |
| A. | Sun Pharma |
| B. | Genova |
| C. | Cipla |
| D. | Lupin Limited |
| E. | Aurobindo Pharma |
| Answer» C. Cipla | |